Clinical results of latamoxef on pertussis
Minamitani, M.; Hachimori, K.; Nakazawa, S.; Sato, H.; Narita, A.; Hirama, Y.; Nakazawa, S.; Chikaoka, H.; Motohiro, T.; Nishiyama, T.; Fujimoto, T.; Ishimoto, K.; Tominaga, K.; Yamashita, F.; Matsuo, H.; Koga, Y.; Eto, Y.; Matsuyuki, M.; Yuasa, T.; Tanaka, Y.; Nagayama, K.; Shimada, Y.; Aramaki, S.; Takajo, N.; Araki, H.; Kawano, Y.
Japanese Journal of Antibiotics 36(2): 233-240
1983
ISSN/ISBN: 0368-2781 PMID: 6304367 Document Number: 199728
Document emailed within 1 workday
Related Documents
Uete, T.; Matsuo, K. 1987: Clinical laboratory approach for estimating the effective administrative dose of latamoxef. Significance of a 4-category system interpretation of the latamoxef disc susceptibility test Japanese Journal of Antibiotics 40(11): 1906-1916Isomura, S.; Suzuki, S.; Sato, Y. 1985: Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients Developments in Biological Standardization 61: 531-537
Chodorowska, M. 1999: Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. II. Occurence and level of B. pertussis antigens in children with suspected whooping cough Medycyna Doswiadczalna i Mikrobiologia 51(3-4): 269-280
Frühwirth, M.; Wolf, H.; Heininger, H.; Guggenbichler, J.P.; Stehr, E. 1995: Secretory IgA against pertussis toxin and surface structures of Bordetella pertussis in saliva of children with culture proven pertussis Advances in Experimental Medicine and Biology 371b: 777-783
Mori, Y.; Hirayama, T.; Kikuchi, K. 1983: Experimental and clinical studies of latamoxef in intestinal surgery Japanese Journal of Antibiotics 36(8): 2093-2097
Takase, Z.; Shirafuji, H.; Matsuda, S.; Tanno, M.; Kashiwakura, T.; Cho, N.; Fukunaga, K.; Kunii, K.; Hogaki, M.; Muronosono, E.; Matsumoto, Y.; Tabei, T.; Hayashi, S.; Nakamura, H.; Seki, K.; Fukuda, T.; Aoyama, S.; Kurasawa, S.; Ninomiya, K.; Hiraoka, O.; Nakai, T.; Shimizu, H.; Sugimoto, O.; Kamiyoshi, S.; Watanabe, K.; Fujimoto, A.; Doi, S.; Jujii, K.; Yamada, F.; Ozawa, M.; Shimizu, T.; Risai, T.; Morimoto, N.; Kobayashi, H.; Kondo, I.; Saita, K.; Ibaragi, K.; Kamigawara, Y.; Sawaragi, I.; Yuasa, M.; Hirabayashi, K.; Okada, E.; Shirakawa, K.; Oniki, K.; Yamamoto, K.; Yamabe, T.; Motomura, R.; Nakanishi, K.; Teramoto, C.; Haraguchi, H. 1983: Laboratory and clinical studies on latamoxef in the field of obstetrics and gynecology Japanese Journal of Antibiotics 36(1): 1-15
Miyake, S.; Tanigawa, M.; Manabe, T.; Asano, T.; Niimi, H.; Kamata, I. 1985: Clinical experience of latamoxef in the field of neurosurgery on the penetration into the cerebrospinal fluid in the patients with postoperative meningitis Japanese Journal of Antibiotics 38(12): 3464-3470
Miura, S. 1968: Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on immunity to pertussis, diphtheria and tetanus. 1. Results of the initial immunization Nihon Shonika Gakkai Zasshi. Acta Paediatrica Japonica 72(6): 767-781
Adonajlo, A.; Mazurowska-Magdzik, M.; Pstragowska, W.; Dadak, M. 1975: Effect of infectious diseases on levels of pertussis antibodies in children vaccinated against pertussis Przeglad Epidemiologiczny 29(3): 321-326
Corbel, M. J. 1993: Developments in Biological Standardization, volume 73. Pertussis: Evaluation and Research on Acellular Pertussis Vaccines Journal of Medical Microbiology 38(2): 155-156
Siundiukova, R.A.; Basnak'ian, I.A.; Stukalova, N.V.; Aleksakhina, N.N. 1999: The effect of methylated cyclodextrin on pertussis toxin accumulation in a Bordetella pertussis culture in a bioreactor Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 14-17
Blumberg, D.A.; Pineda, E.; Cherry, J.D.; Caruso, A.; Scott, J.V. 1992: The agglutinin response to whole-cell and acellular pertussis vaccines is Bordetella pertussis--strain dependent American Journal of Diseases of Children 146(10): 1148-1150
Hinman, A.R.; Koplan, J.P. 1984: Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs JAMA 251(23): 3109-3113
Shahdadpuri, R.I.; Nicholson, A.J.; Bedford, D.; O'Flanagan, D. 2004: Pertussis--going, going, but not gone: thirteen year trends in the incidence of pertussis in the Republic of Ireland and North Eastern Health Board Irish Medical Journal 97(2): 44-46
Schneerson, R.; Robbins, J.B.; Taranger, J.; Lagerård, T.; Trollfors, B. 1997: Examination of similarities between diphtheria and pertussis and their toxoids provide insight into vaccine-induced protection to Bordetella pertussis Developments in Biological Standardization 89: 321-326
Lau, R.C. 1989: Pertussis (whooping cough) toxin and Bordetella pertussis whole-cell antibody levels in a healthy New Zealand population New Zealand Medical Journal 102(878): 560-562
Edwards, K.M.; Lawrence, E.; Wright, P.F. 1986: Diphtheria, tetanus, and pertussis vaccine. A comparison of the immune response and adverse reactions to conventional and acellular pertussis components American Journal of Diseases of Children 140(9): 867-871
Chuprinina, R.P.; Alekseeva, I.A.; Ozeretskovskiĭ, N.A. 2006: Prophylaxis of pertussis: development and use of acellular pertussis vaccine Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2006(1): 99-105
Rastawicki, W.; Smietańska, K.; Rokosz-Chudziak, N.; Jagielski, M. 2013: Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough Medycyna Doswiadczalna i Mikrobiologia 65(4): 269-274
Mills, K.H.; Brady, M.; Ryan, E.; Mahon, B.P. 1998: A respiratory challenge model for infection with Bordetella pertussis: application in the assessment of pertussis vaccine potency and in defining the mechanism of protective immunity Developments in Biological Standardization 95: 31-41